According to Xtant Medical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.02702. At the end of 2023 the company had a P/S ratio of 1.61.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.61 | 30.16% |
2022 | 1.24 | 40.22% |
2021 | 0.8823 | -49.28% |
2020 | 1.74 | 434.31% |
2019 | 0.3256 | 10.85% |
2018 | 0.2937 | 133.22% |
2017 | 0.1259 | 19.48% |
2016 | 0.1054 | -81.22% |
2015 | 0.5613 | -2.01% |
2014 | 0.5728 | -29.09% |
2013 | 0.8078 | -50.29% |
2012 | 1.63 | -57.8% |
2011 | 3.85 | -81.12% |
2010 | 20.4 |